menu Search
DKSH

JANSSEN-CILAG LTD

Featured products of Janssen-Cilag
Balversa
Balversa FC tab 3 mg
erdafitinib
Packing/Price
2 × 42's2 × 28's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01EN01 - erdafitinib : Belongs to the class of Fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitors. Used in the treatment of cancer.
Balversa FC tab 4 mg
erdafitinib
Packing/Price
1 × 14's2 × 28's1 × 28's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01EN01 - erdafitinib : Belongs to the class of Fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitors. Used in the treatment of cancer.
Balversa FC tab 5 mg
erdafitinib
Packing/Price
1 × 28's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01EN01 - erdafitinib : Belongs to the class of Fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitors. Used in the treatment of cancer.
Darzalex
Darzalex conc for soln for infusion 100 mg/5 mL
daratumumab
Packing/Price
1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01FC01 - daratumumab : Belongs to the class of CD38 (Clusters of Differentiation 38) inhibitors. Used in the treatment of cancer.
Darzalex conc for soln for infusion 400 mg/20 mL
daratumumab
Packing/Price
1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01FC01 - daratumumab : Belongs to the class of CD38 (Clusters of Differentiation 38) inhibitors. Used in the treatment of cancer.
Darzalex SC
Darzalex SC soln for inj
daratumumab, hyaluronidase
Packing/Price
15 mL x 1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01FC01 - daratumumab : Belongs to the class of CD38 (Clusters of Differentiation 38) inhibitors. Used in the treatment of cancer.
Erleada
Erleada FC tab 60 mg
apalutamide
Packing/Price
120's
MIMS Class
Cancer Hormone Therapy
ATC Classification
L02BB05 - apalutamide : Belongs to the class of anti-androgens. Used in treatment of neoplastic diseases.
Imbruvica
Imbruvica cap 140 mg
ibrutinib
Packing/Price
1 × 120's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01EL01 - ibrutinib : Belongs to the class of Bruton's tyrosine kinase (BTK) inhibitors. Used in the treatment of cancer.
Imbruvica FC tab 140 mg
ibrutinib
Packing/Price
3 × 10's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01EL01 - ibrutinib : Belongs to the class of Bruton's tyrosine kinase (BTK) inhibitors. Used in the treatment of cancer.
Rybrevant
Rybrevant conc for soln for infusion 350 mg/7 mL
amivantamab
Packing/Price
1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01FX18 - amivantamab : Belongs to the class of other monoclonal antibodies and antibody drug conjugates. Used in the treatment of cancer.
Tecvayli
Tecvayli soln for inj 10 mg/mL
teclistamab
Packing/Price
((3 mL)) 1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01FX24 - teclistamab : Belongs to the class of other monoclonal antibodies and antibody drug conjugates. Used in the treatment of cancer.
Tecvayli soln for inj 90 mg/mL
teclistamab
Packing/Price
((1.7 mL)) 1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01FX24 - teclistamab : Belongs to the class of other monoclonal antibodies and antibody drug conjugates. Used in the treatment of cancer.
Distributed by DKSH
Balversa
Balversa FC tab 3 mg
erdafitinib
Packing/Price
2 × 42's2 × 28's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01EN01 - erdafitinib : Belongs to the class of Fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitors. Used in the treatment of cancer.
Balversa FC tab 4 mg
erdafitinib
Packing/Price
1 × 14's2 × 28's1 × 28's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01EN01 - erdafitinib : Belongs to the class of Fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitors. Used in the treatment of cancer.
Balversa FC tab 5 mg
erdafitinib
Packing/Price
1 × 28's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01EN01 - erdafitinib : Belongs to the class of Fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitors. Used in the treatment of cancer.
Darzalex
Darzalex conc for soln for infusion 100 mg/5 mL
daratumumab
Packing/Price
1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01FC01 - daratumumab : Belongs to the class of CD38 (Clusters of Differentiation 38) inhibitors. Used in the treatment of cancer.
Darzalex conc for soln for infusion 400 mg/20 mL
daratumumab
Packing/Price
1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01FC01 - daratumumab : Belongs to the class of CD38 (Clusters of Differentiation 38) inhibitors. Used in the treatment of cancer.
Darzalex SC
Darzalex SC soln for inj
daratumumab, hyaluronidase
Packing/Price
15 mL x 1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01FC01 - daratumumab : Belongs to the class of CD38 (Clusters of Differentiation 38) inhibitors. Used in the treatment of cancer.
Erleada
Erleada FC tab 60 mg
apalutamide
Packing/Price
120's
MIMS Class
Cancer Hormone Therapy
ATC Classification
L02BB05 - apalutamide : Belongs to the class of anti-androgens. Used in treatment of neoplastic diseases.
Imbruvica
Imbruvica cap 140 mg
ibrutinib
Packing/Price
1 × 120's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01EL01 - ibrutinib : Belongs to the class of Bruton's tyrosine kinase (BTK) inhibitors. Used in the treatment of cancer.
Imbruvica FC tab 140 mg
ibrutinib
Packing/Price
3 × 10's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01EL01 - ibrutinib : Belongs to the class of Bruton's tyrosine kinase (BTK) inhibitors. Used in the treatment of cancer.
Rybrevant
Rybrevant conc for soln for infusion 350 mg/7 mL
amivantamab
Packing/Price
1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01FX18 - amivantamab : Belongs to the class of other monoclonal antibodies and antibody drug conjugates. Used in the treatment of cancer.